Protalix BioTherapeutics announced that it received a deficiency letter from NYSE American LLC stating that the company is not in compliance with the continued listing standards as set forth in Section 1003ai - iii of the NYSE American Company Guide as it has reported a stockholders' equity
deficiency as of June 30, 2019 and net losses in its five most recent fiscal years ended December 31, 2018.
As previously reported on May 23, 2019, Therapix received a letter notifying the Company that the stockholders' equity
reported in the Company's Annual Report on Form 20-F for the year ended December 31, 2018, was below the minimum stockholders' equity
of $2,500,000 required for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq listing rule 5550(b)(1).
(NYSE American: NBY) has received notice from the NYSE American LLC that it is not in compliance with Sections 1003(a) (i) and 1003(a) of the NYSE American company Guide requiring stockholders' equity
of USD 2m or more and USD 4m or more, respectively, if the company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years, the company said.
The company is not in compliance as its stockholders' equity
is required to be USD4.0m, or more if it has reported net losses in three of its last four fiscal years (the Stockholders' Equity
The Bank's annualized returns on average assets, average common stockholders' equity
and average tangible common stockholders' equity
for the second quarter of 2018 were 2.10%, 12.90% and 16.08%, respectively, compared to 1.90%, 12.05% and 15.81%, respectively, for the second quarter of 2017.
While our losses for the quarter were unacceptably high, our investment yields improved and we took steps to contain our costs by reducing our workforce and implementing a rate increase and underwriting restrictions." Stockholders' equity
was $56.8 million as of March 31, 2018, or $10.71 per common share including unrealized after-tax investment losses of $1.1 million, compared to stockholders' equity
of $59.9 million as of December 31, 2017, or $11.30 per common share including unrealized after-tax investment losses of $0.2 million.
The requirement states that a company's stockholders' equity
be USD 2.0 million or more if it has reported net losses in two of its last three fiscal years.
As previously reported, the exchange ratio and per share cash consideration are subject to adjustment based on the amount of Polonia's consolidated stockholders' equity
at a specified date prior to closing as calculated in accordance with the merger agreement.
If fully subscribed the proceeds received would be in excess of the amount required for the company to evidence compliance with the alternative USD2.5 million stockholders' equity
requirement, in which case the company expects it would be deemed by NASDAQ to have satisfied the Rule, thereby closing this matter.
Balance sheets are divided into two halves (groups): (1) Assets and (2) Liabilities and Stockholders' Equity
. The Assets group includes subgroups such as Property, Plant, and Equipment and Current Assets.
Bank of the Ozarks reported annualized returns on average assets of 5.24 percent and on average common stockholders' equity
of 55.88 percent for the second quarter.
* Your creditors may object since the stockholders' equity
account drops after a redemption.